Abstract:Wolbachia , a maternally transmitted symbiotic bacterium of insects, can suppress a variety of human pathogens in mosquitoes, including malaria-causing Plasmodium in the Anopheles vector. However, the mechanistic basis of Wolbachia -mediated Plasmodium suppression in mosquitoes is not well understood. In this study, we compared the midgut and carcass transcriptomes of stably infected Anopheles stephensi with Wolbachia w AlbB to uninfected mosquitoes in order to discover Wolbachia infection-responsive immune genes that may play a role in Wolbachia -mediated anti- Plasmodium activity. We show that w AlbB infection upregulates 10 putative immune genes and downregulates 14 in midguts, while it upregulates 31 putative immune genes and downregulates 15 in carcasses at 24 h after blood-fed feeding, the time at which the Plasmodium ookinetes are traversing the midgut tissue. Only a few of these regulated immune genes were also significantly differentially expressed between Wolbachia -infected and non-infected midguts and carcasses of sugar-fed mosquitoes. Silencing of the Wolbachia infection-responsive immune genes TEP 4 , TEP 15 , lysozyme C2 , CLIPB2 , CLIPB4 , PGRP-LD and two novel genes (a peritrophin-44-like gene and a macro domain-encoding gene ) resulted in a significantly greater permissiveness to P . falciparum infection. These results indicate that Wolbachia infection modulates mosquito immunity and other processes that are likely to decrease Anopheles permissiveness to Plasmodium infection. Wolbachia is a maternally transmitted symbiotic bacterium of many insects, and in certain vector mosquitoes it can suppress human pathogens including dengue virus in Aedes mosquitoes and malaria-causing Plasmodium in the Anopheles vector. The mechanism by which Wolbachia infection of the mosquito suppresses the Plasmodium parasite is not well understood. In this study, we compared expression of Anopheles stephensi genes with and without Wolbachia infection to discover Wolbachia infection-responsive immune genes that may be responsible for Plasmodium suppression as part of the mosquitoes anti- Plasmodium immune response. We show that Wolbachia infection of the Anopheles stephensi malaria vector mosquito will regulate numerous putative mosquito immune genes the time at which the Plasmodium ookinetes are traversing the midgut tissue after ingestion of an infectious blood meal. We also show through functional studies that several of the Wolbachia infection-responsive immune genes TEP 4 , TEP 15 , lysozyme C2 , CLIPB2 , CLIPB4 , PGRP-LD and two novel genes (a peritrophin-44-like gene and a macro domain-encoding gene ) are indeed involved in suppressing P . falciparum infection. Our study show that Wolbachia infection modulates mosquito immunity and other processes that are likely to impact Anopheles ability to transmit malaria.

Dihydroartemisinin suppresses the susceptibility of Anopheles stephensi to Plasmodium yoelii by activating the Toll signaling pathway

Dihydroartemisinin regulates the immune system by promotion of CD8+ T lymphocytes and suppression of B cell responses

Dihydroartemisinin regulates immune cell heterogeneity by triggering a cascade reaction of CDK and MAPK phosphorylation

Synthesis, in Vitro and in Vivo Biological Evaluation of Dihydroartemisinin Derivatives with Potential Anti-Toxoplasma Gondii Agents.

Human Defensin 5 Inhibits Plasmodium yoelii Development in Anopheles stephensi by Promoting Innate Immune Response

Dihydroartemisinin Ameliorates Inflammatory Disease by Its Reciprocal Effects on Th and Regulatory T Cell Function Via Modulating the Mammalian Target of Rapamycin Pathway

Effects of artemisinin, dihydroartemisinin and arteether on immune responses of normal mice

Dihydroartemisinin Beneficially Regulates Splenic Immune Cell Heterogeneity Through the SOD3-JNK-AP-1 Axis

Metabolite Profiling of Dihydroartemisinin in Blood of <i>Plasmodium</i>-Infected and Healthy Mice Using UPLC-Q-TOF-MS<SUP>E</SUP>

Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling pathways.

Effects of Dihydroartemisinin on Immune Function in Balb/c Mice

Mechanisms of in vitro resistance to dihydroartemisinin in Plasmodium falciparum.

Artemisinin inhibits TLR4 signaling by targeting co‐receptor MD2 in microglial BV‐2 cells and prevents lipopolysaccharide‐induced blood–brain barrier leakage in mice

Progress on the Study of Anti-tumor Mechanisms of Dihydroartemisinin

Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice

Can artemisinin and its derivatives treat malaria in a host-directed manner?

Immunosuppressive effect of dihydroartemisinin on murine T lymphocytes

Wolbachia infection-responsive immune genes suppress Plasmodium falciparum infection in Anopheles stephensi

Role of Dihydroartemisinin in Regulating Prostaglandin E2 Synthesis Cascade and Inflammation in Endothelial Cells.

Dihydroartemisinin Attenuates Lipopolysaccharide-Induced Acute Lung Injury In Mice By Suppressing Nf-Kappa B Signaling In An Nrf2-Dependent Manner

The Anti-Malarial Artemisinin Inhibits Pro-Inflammatory Cytokines Via the NF-ÎºB Canonical Signaling Pathway in PMA-induced THP-1 Monocytes